SK285989B6 - Cyklické alfa-amino-gama-hydroxyamidy, spôsob ichprípravy a farmaceutické prostriedky, ktoré ich obsahujú - Google Patents

Cyklické alfa-amino-gama-hydroxyamidy, spôsob ichprípravy a farmaceutické prostriedky, ktoré ich obsahujú Download PDF

Info

Publication number
SK285989B6
SK285989B6 SK877-2002A SK8772002A SK285989B6 SK 285989 B6 SK285989 B6 SK 285989B6 SK 8772002 A SK8772002 A SK 8772002A SK 285989 B6 SK285989 B6 SK 285989B6
Authority
SK
Slovakia
Prior art keywords
formula
compound
amino
ethyl
oxo
Prior art date
Application number
SK877-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK8772002A3 (en
Inventor
Michel Wierzbicki
Jean-Marie Fourquez
Nigel Levens
Olivier Nosjean
Michelle Boulanger
Bernadette Husson-Robert
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of SK8772002A3 publication Critical patent/SK8772002A3/sk
Publication of SK285989B6 publication Critical patent/SK285989B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/14—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK877-2002A 2001-06-18 2002-06-18 Cyklické alfa-amino-gama-hydroxyamidy, spôsob ichprípravy a farmaceutické prostriedky, ktoré ich obsahujú SK285989B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0107934A FR2826003B1 (fr) 2001-06-18 2001-06-18 Nouveaux derives cycliques d'alpha-amino-gamma-hydroxy- amides, leur procede de preparation et les compositions pharmaceutiques que les contiennent

Publications (2)

Publication Number Publication Date
SK8772002A3 SK8772002A3 (en) 2003-01-09
SK285989B6 true SK285989B6 (sk) 2008-01-07

Family

ID=8864417

Family Applications (1)

Application Number Title Priority Date Filing Date
SK877-2002A SK285989B6 (sk) 2001-06-18 2002-06-18 Cyklické alfa-amino-gama-hydroxyamidy, spôsob ichprípravy a farmaceutické prostriedky, ktoré ich obsahujú

Country Status (25)

Country Link
US (1) US6593312B2 (ja)
EP (1) EP1270562B1 (ja)
JP (1) JP2003012642A (ja)
CN (1) CN1178901C (ja)
AR (1) AR034516A1 (ja)
AT (1) ATE277027T1 (ja)
AU (1) AU781822B2 (ja)
BR (1) BR0202313A (ja)
CA (1) CA2389858C (ja)
CZ (1) CZ20022119A3 (ja)
DE (1) DE60201296T2 (ja)
DK (1) DK1270562T3 (ja)
EA (1) EA004955B1 (ja)
ES (1) ES2229063T3 (ja)
FR (1) FR2826003B1 (ja)
HK (1) HK1050186A1 (ja)
HU (1) HUP0202011A3 (ja)
MX (1) MXPA02005997A (ja)
NO (1) NO322155B1 (ja)
NZ (1) NZ519610A (ja)
PL (1) PL354565A1 (ja)
PT (1) PT1270562E (ja)
SI (1) SI1270562T1 (ja)
SK (1) SK285989B6 (ja)
ZA (1) ZA200204865B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002306823B2 (en) * 2001-03-27 2006-05-11 Merck & Co., Inc. Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122010000020I1 (de) * 1996-04-25 2010-07-08 Prosidion Ltd Verfahren zur Senkung des Blutglukosespiegels in Säugern

Also Published As

Publication number Publication date
EA004955B1 (ru) 2004-10-28
EP1270562A3 (fr) 2003-05-07
CN1392137A (zh) 2003-01-22
AU4882202A (en) 2002-12-19
CZ20022119A3 (cs) 2003-02-12
PT1270562E (pt) 2004-11-30
PL354565A1 (en) 2002-12-30
DE60201296T2 (de) 2006-02-23
JP2003012642A (ja) 2003-01-15
CN1178901C (zh) 2004-12-08
DE60201296D1 (de) 2004-10-28
DK1270562T3 (da) 2005-01-24
EP1270562A2 (fr) 2003-01-02
NO20022891L (no) 2002-12-19
US6593312B2 (en) 2003-07-15
FR2826003A1 (fr) 2002-12-20
EA200200574A1 (ru) 2002-12-26
HK1050186A1 (en) 2003-06-13
NZ519610A (en) 2003-05-30
FR2826003B1 (fr) 2003-08-15
HUP0202011A3 (en) 2005-07-28
BR0202313A (pt) 2003-04-29
NO20022891D0 (no) 2002-06-17
SI1270562T1 (en) 2004-12-31
CA2389858A1 (fr) 2002-12-18
ATE277027T1 (de) 2004-10-15
ZA200204865B (en) 2003-02-20
SK8772002A3 (en) 2003-01-09
CA2389858C (fr) 2007-08-28
HU0202011D0 (ja) 2002-08-28
US20030004138A1 (en) 2003-01-02
AU781822B2 (en) 2005-06-16
EP1270562B1 (fr) 2004-09-22
ES2229063T3 (es) 2005-04-16
NO322155B1 (no) 2006-08-21
HUP0202011A2 (hu) 2003-01-28
MXPA02005997A (es) 2005-02-17
AR034516A1 (es) 2004-02-25

Similar Documents

Publication Publication Date Title
US7612210B2 (en) Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
US7399779B2 (en) 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists
KR20020087379A (ko) 신규 α-아미노산 화합물, 이의 제조 방법 및 이를함유하는 약제학적 조성물
KR100747967B1 (ko) 피롤리딘 및 티아졸리딘 화합물, 이의 제조 방법 및 이를함유하는 약제 조성물
US20080262075A1 (en) Pyrrolidine Derivatives as Muscarinic Receptor Antagonists
US7517905B2 (en) Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
BG64701B1 (bg) Метод за получаване на 2-азадихидроксибицикло[2.2.1]хептаново съединение и сол на съединението и l-винена киселина
JPH10503503A (ja) 神経安定剤として有用なｎ−置換された３−アザビシクロ（３．２．０）ヘプタン誘導体
SK285989B6 (sk) Cyklické alfa-amino-gama-hydroxyamidy, spôsob ichprípravy a farmaceutické prostriedky, ktoré ich obsahujú
KR100503156B1 (ko) 신규한 고리형 α-아미노-γ-히드록시아미드 화합물, 그의제조방법 및 그를 함유한 약학적 조성물
SK115396A3 (en) Regiospecific processes to make cis-1-amino-2-alkanols
KR910003711B1 (ko) 2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법
EP1511728B1 (fr) Derives d oxophenyl-cyclohexyl-propanolamine, leur preparati on et leur application en therapeutique
JPH02164882A (ja) スピロ化合物及びその中間体
ES2286240T3 (es) Derivados sustituidos de propano-1,3-diamina y su utilizacion farmaceutoca de los mismos.
JP2020530441A (ja) アザ糖とその中間体の合成
KR102645695B1 (ko) 페닐티오우레아 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 글루타미닐 사이클레이즈 활성 관련 질환의 예방 또는 치료용 약학적 조성물
HU194157B (en) Process for production of derivatives of prophil-amin and medical compounds containing thereof
FR2944284A1 (fr) Derives de n-°7-aza-bicyclo°2.2.1!hept-1-yl)-aryl-methyl! -benzamide, leur preparation et leur application en therapeutique
WO2010092286A1 (fr) Derives de n-[(2-aza-bicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique
CA2667222A1 (en) Novel process

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090618